Thanks and I love this line in particular--"As each of the trials will be open-label, the company may, once the trials commence, be able to share details on the safety profile and response of the patients prior to the end of the trials." GLTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.